PEA15 and cancer: In recent years, the multifaceted interactions and numerous biological pathways that are involved and regulated by phosphoprotein enriched in astrocytes-15 kDa (PEA-15), a death effector domain (DED) containing protein, have drawn significant attention in the fields of cancer, diabetes, and neurodegenerative diseases [1,2].